This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Eisai R&d Management Co., Ltd., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Wyeth. Active years: 2009-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 530 
1 out of 3,693 
1 out of 1,309 
Years Active: 2009-2017
Title: Unveiling the Innovative Work of Inventor Michael Chapman Byrne
Introduction:
In the realm of cutting-edge inventions and breakthrough innovations, inventor Michael Chapman Byrne emerges as a prominent figure. Hailing from Brookline, MA (US), his inventive spirit and ingenuity have led to the creation of remarkable patents that hold immense potential in the fields of medical research and immunology.
Latest Patents:
1. Methods and compositions for predicting response to eribulin: Michael Byrne's invention introduces groundbreaking methods for predicting the efficacy of eribulin in treating breast cancer by analyzing specific biomarkers in patient samples.
2. Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies: Byrne's innovative patent presents novel polynucleotides and polypeptides related to a ligand for glucocorticoid-induced TNF receptor (GITR), offering new avenues for diagnosing, monitoring, and treating immune system disorders.
Career Highlights:
Throughout his illustrious career, Michael Chapman Byrne has made significant contributions to renowned organizations such as Wyeth and The United States of America (represented by the Secretary of the Department of Health and Human Services). His work stands as a testament to his dedication to advancing the frontiers of science and medicine.
Collaborations:
In his professional journey, Byrne has had the privilege of collaborating with esteemed coworkers such as Mary Collins and Ethan Shevach. Together, they have synergized their expertise to drive forward innovative initiatives and research endeavors in the domain of medical innovation.
Conclusion:
Inventor Michael Chapman Byrne's remarkable achievements underscore his profound impact on the fields of medical research and immunology. His pioneering patents and collaborative efforts exemplify a commitment to pushing boundaries, fostering advancements, and improving the well-being of individuals worldwide. As we look to the future, Byrne's legacy serves as inspiration for aspiring inventors and innovators seeking to make a difference in the world of science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile